Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Familial Chylomicronemia Syndrome

Metabolic & Lysosomal

Familial Chylomicronemia Syndrome (FCS) Clinical Trials

Also called FCS, Lipoprotein Lipase Deficiency, Type I Hyperlipoproteinemia, Familial Hyperchylomicronemia, LPL Deficiency

Familial Chylomicronemia Syndrome is caused by mutations in genes that control how the body breaks down certain types of fat after eating. Without working enzymes to process triglycerides, dangerous levels accumulate in the bloodstream. The most serious complication is acute pancreatitis, which can be life-threatening and occur repeatedly, leading to permanent pancreatic damage over time.

In plain words, familial chylomicronemia syndrome is a rare inherited condition where the body cannot break down certain fats in the blood called triglycerides. These fats build up to very high levels, which can lead to repeated attacks of painful swelling in the pancreas.

Get an email when new Familial Chylomicronemia Syndrome trials open or the FDA decides. Get alerts

Familial Chylomicronemia Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

FDA review0

No decision pending. FDA calendar

FDA-approved medicines2

Redemplo · Tryngolza

Familial Chylomicronemia Syndrome has 2 FDA-approved medicines, 2 open or active clinical trials (2 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Familial Chylomicronemia Syndrome

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Familial Chylomicronemia Syndrome

People with FCS manage their condition primarily through strict low-fat diets (typically under 20 grams daily) and medium-chain triglyceride (MCT) supplements. Avoiding alcohol and certain medications is critical. New medications have become available to help lower triglyceride levels and reduce pancreatitis risk, offering patients better control than diet alone.

Keep reading about Familial Chylomicronemia Syndrome

Early diagnosis and treatment are essential to prevent serious complications and improve long-term outcomes. Genetic counseling is recommended for families, as the condition is inherited and each sibling has a 25% chance of being affected.

What are the symptoms of Familial Chylomicronemia Syndrome?

These are common symptoms of Familial Chylomicronemia Syndrome, and how strong they are varies from person to person.

  • Severe abdominal pain, often from repeated pancreatitis episodes
  • Extremely high triglyceride levels in blood (often above 1,000mg/dL)
  • Nausea and vomiting
  • Fatigue and low energy
  • Fatty yellow bumps on skin (eruptive xanthomas)
  • Enlarged spleen or liver

Who gets Familial Chylomicronemia Syndrome?

FCS typically appears in childhood or early adulthood when people inherit genetic mutations from both parents (autosomal recessive). It affects males and females equally. About 80% of cases result from mutations in the lipoprotein lipase (LPL) gene, while mutations in APOC2, APOA5, GPIHBP1, and LMF1 account for the rest.

Next steps: find trials you might fitcompare treatmentsget help payingget alerts

Which medicines are FDA-approved for Familial Chylomicronemia Syndrome?

There are currently 2 FDA-approved medications for Familial Chylomicronemia Syndrome.

Side by sideCompare all 2 side by sideHow each of the medicines is taken, what the trials showed and the warnings on the label, in plain language.Open the comparison
Just prescribed one of these?Your first 90 days, step by stepWhat happens before the first fill, the tests and refills to expect, and help paying, with a one-page handout to print.
plozasiran
Your first 90 days
Arrowhead Pharmaceuticals
Search
olezarsen
Your first 90 days
Ionis Pharmaceuticals
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Familial Chylomicronemia Syndrome treatment

Charity funds and drugmaker programs for Familial Chylomicronemia Syndrome, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds
  • From a charity · The Assistance Fund
    Familial Chylomicronemia Syndrome (FCS) fund
    Open

    Pays for: Copays, coinsurance, deductibles and other health-related expenses.

Status as each foundation showed it on November 20, 2026.
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Every program and fund for Familial Chylomicronemia Syndrome, by insurance →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Familial Chylomicronemia Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Familial Chylomicronemia Syndrome resources

Reputable organizations and medical references for learning more about Familial Chylomicronemia Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Familial Chylomicronemia Syndrome

Use this Familial Chylomicronemia Syndrome clinical trial finder to see the 2 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. All of them test a treatment. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

2 active trials worldwide
Filter:
Sort:
RecruitingTreatment trialPhase 3Recently updatedNCT07727538

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

Intervention: Olezarsen

Sponsor: Ionis Pharmaceuticals, Inc.

The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.

Ages 2 Years to 17 Years
Started Jul 2026Updated 2 weeks agoEst. Aug 2030 (~3y 9m)
RecruitingTreatment trialEarly Phase 1No updates in a whileNCT07176923

CS-121 APOC3 Base Editing in FCS

Intervention: CS-121

Sponsor: CorrectSequence Therapeutics Co., Ltd

This is an open-label, single-arm, dose-escalation Phase I clinical trial to evaluate the safety, tolerability, pharmacodynamics (PD), and pharmacokinetics (PK) of CS-121, an in vivo base editing therapy delivered by lipid nanoparticles targeting APOC3, in adult participants (18-...

Ages 18 Years to 55 Years1 location
Started Oct 2025Updated 9 months agoEst. Dec 2026 (~1 month)
Find Familial Chylomicronemia Syndrome trials near you, ranked by distance →
Active trial locations6 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Oct 2025 to Aug 2031
2026
2027
2028
2029
2030
2031
now
Early Phase 1
Phase 3
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Familial Chylomicronemia Syndrome trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Familial Chylomicronemia Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Familial Chylomicronemia Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Familial Chylomicronemia Syndrome patients, caregivers and advocacy groups talk.

Familial Chylomicronemia Syndrome news and guides

Trial Friend articles about Familial Chylomicronemia Syndrome, newest first

Companies developing Familial Chylomicronemia Syndrome treatments

Drugmakers that list Familial Chylomicronemia Syndrome in their rare disease portfolio, 4 in all.

Questions people ask about Familial Chylomicronemia Syndrome